Sirtuin deacylases: a molecular link between metabolism and immunity (Q28283588)

Journal of Leukocyte Biology

Europe PubMed Central

title

Sirtuin deacylases: a molecular link between metabolism and immunity (English)

0 references

2

Oberdan Leo

0 references

author name string

Nicolas Preyat

series ordinal

1

0 references

language of work or name

English

0 references

publication date

May 2013

0 references

published in

0 references

volume

93

0 references

issue

5

0 references

page(s)

669-80

0 references

cites work

Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

The first identification of lysine malonylation substrates and its regulatory enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Recent progress in the biology and physiology of sirtuins

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Reconstructing eukaryotic NAD metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Coenzyme specificity of Sir2 protein deacetylases: implications for physiological regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

A continuous microplate assay for sirtuins and nicotinamide-producing enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Serum levels of visfatin and omentin-1 in patients with psoriasis and their relation to disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Visfatin, an adipocytokine with proinflammatory and immunomodulating properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Catastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

The NAMPT inhibitor FK866 reverts the damage in spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Inhibition of pre-B cell colony-enhancing factor attenuates inflammation and apoptosis induced by pandemic H1N1 2009 in lung endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Sirtinol treatment reduces inflammation in human dermal microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

High-fat diet triggers inflammation-induced cleavage of SIRT1 in adipose tissue to promote metabolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Fasting promotes the expression of SIRT1, an NAD+ -dependent protein deacetylase, via activation of PPARalpha in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Shared principles in NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Myeloid deletion of SIRT1 induces inflammatory signaling in response to environmental stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Sirt1 protects against high-fat diet-induced metabolic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

SIRT1 promotes cell survival under stress by deacetylation-dependent deactivation of poly(ADP-ribose) polymerase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

SIRT2 regulates NF-κB dependent gene expression through deacetylation of p65 Lys310

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

SIRT1 inhibits transforming growth factor beta-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Mechanical stress-activated immune response genes via Sirtuin 1 expression in human periodontal ligament cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

HMGB1 is a therapeutic target for sterile inflammation and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Genomic instability and aging-like phenotype in the absence of mammalian SIRT6

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Progression of chronic liver inflammation and fibrosis driven by activation of c-JUN signaling in Sirt6 mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Aerobic glycolysis: meeting the metabolic requirements of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Metabolism in T cell activation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

NAD+-dependent sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Evidence that hypoxia-inducible factor-1 (HIF-1) mediates transcriptional activation of interleukin-1beta (IL-1beta) in astrocyte cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Influence of hypoxia-inducible factor 1α on dendritic cell differentiation and migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

The updated biology of hypoxia-inducible factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

GCN5-mediated transcriptional control of the metabolic coactivator PGC-1beta through lysine acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Metabolic checkpoints in activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Fueling the flame: bioenergy couples metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

NAD+-dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Sirtuin 1 and sirtuin 3: physiological modulators of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Sirtuin inhibition attenuates the production of inflammatory cytokines in lipopolysaccharide-stimulated macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Nicotinamide is a potent inhibitor of proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Nicotinamide does not influence cytokines or exhaled NO in human experimental endotoxaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Cigarette smoke-induced autophagy is regulated by SIRT1-PARP-1-dependent mechanism: implication in pathogenesis of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

PARP-1 inhibition does not restore oxidant-mediated reduction in SIRT1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Complex roles of members of the ADP-ribosyl transferase super family in immune defences: looking beyond PARP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Use of a poly(ADP-ribose) polymerase inhibitor to suppress inflammation and neuronal death after cerebral ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Resveratrol suppresses interferon-gamma-induced biochemical pathways in human peripheral blood mononuclear cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Chronic resveratrol intake reverses pro-inflammatory cytokine profile and oxidative DNA damage in ageing hybrid mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Resveratrol mitigates lipopolysaccharide- and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Oral resveratrol reduces neuronal damage in a model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Resveratrol (trans-3,5,4'-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Effect of resveratrol on activation of nuclear factor kappa-B and inflammatory factors in rat model of acute pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Effect of resveratrol in experimental osteoarthritis in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Discovery of oxazolo[4,5-b]pyridines and related heterocyclic analogs as novel SIRT1 activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Discovery of imidazo[1,2-b]thiazole derivatives as novel SIRT1 activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

The Tellurium compound, AS101, increases SIRT1 level and activity and prevents type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

SIRT1-independent mechanisms of the putative sirtuin enzyme activators SRT1720 and SRT2183.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

The effect of water-soluble chitosan on macrophage activation and the attenuation of mite allergen-induced airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Chitosan oligosaccharides protect mice from LPS challenge by attenuation of inflammation and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Chitooligosaccharide induces mitochondrial biogenesis and increases exercise endurance through the activation of Sirt1 and AMPK in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Akt/FOXO3a/SIRT1-mediated cardioprotection by n-tyrosol against ischemic stress in rat in vivo model of myocardial infarction: switching gears toward survival and longevity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

Endotoxin tolerance: new mechanisms, molecules and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

The sirtuin SIRT6 deacetylates H3 K56Ac in vivo to promote genomic stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

CBP/p300-mediated acetylation of histone H3 on lysine 56

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557

The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1112557